LMAT insider sale: 6,561 shares via Morgan Stanley valued $607,229
Rhea-AI Filing Summary
LeMaitre Vascular (LMAT) filed a Form 144 reporting a proposed sale of 6,561 common shares through Morgan Stanley Smith Barney LLC on the NASDAQ with an aggregate market value of $607,229.74. The filing lists 22,637,522 shares outstanding and an approximate sale date of 08/11/2025. The securities were acquired by a stock option exercise on 08/11/2025 with payment in cash.
The filing also discloses a recent sale by JOHN ADAM ROUSH of 939 shares on 08/08/2025 for $87,784.39. The notice includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR: Form 144 shows an insider notice to sell 6,561 shares (aggregate $607,229) on NASDAQ; a small prior sale of 939 shares occurred days earlier.
The filing documents a proposed disposition of 6,561 common shares via Morgan Stanley with an aggregate market value of $607,229.74. The filing also records a recent sale of 939 shares producing $87,784.39. Using the filing's figures, the proposed sale represents a very small fraction of the 22,637,522 shares outstanding. The securities were acquired by a stock option exercise on the same listed date and paid in cash, indicating an immediate disposition of exercised shares as reported.
TL;DR: Routine Form 144 disclosure of share sale; seller attests no undisclosed material adverse information.
The notice follows Rule 144 reporting requirements and names the broker (Morgan Stanley Smith Barney LLC) and exchange (NASDAQ). The filing includes the seller's representation that they are unaware of any material nonpublic information. It also lists a recent separate sale by JOHN ADAM ROUSH of 939 shares, with gross proceeds $87,784.39, suggesting multiple short‑interval transactions are reported in the filing.